new boxed warning about serious liver toxicity in patients taking Tasmar (tolcapone)
December 1998
You'll see a new boxed warning about serious liver toxicity in patients taking Tasmar (tolcapone).
Tasmar came out earlier this year. It's used to prolong the effect of levodopa in patients with advanced Parkinson's.
Now there are several reports of liver toxicity...including three deaths.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote